CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project explores the use of engineered non-pathogenic bacteria to dissolve biofilms associated with ventilator-associated pneumonia. It aims to confirm the safety and efficacy of this approach in animal models, potentially leading to innovative treatments for respiratory infections.
Among 65-80% of human infections are associated to biofilms, especially in respiratory infections or those associated with catheters.
Endotracheal tube (ETT) biofilm is related to the development of ventilator-associated pneumonia (VAP), which occurs in 9–27% of all intubated patients.
Those ETT-biofilms are mainly formed by Pseudomonas aeruginosa and/or Staphylococcus aureus, forming a protective barrier against antibiotics and the host immune system.
The consequence of VAP is chronic inflammat…
FUNDACIO CENTRE DE REGULACIO GENOMICA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
